A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates - Centre International de Recherche en Infectiologie Accéder directement au contenu
Article Dans Une Revue Nature Microbiology Année : 2023

A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates

Hervé Raoul

Résumé

Pathogenic New World arenaviruses (NWAs) cause haemorrhagic fevers and can have high mortality rates, as shown in outbreaks in South America. Neutralizing antibodies (Abs) are critical for protection from NWAs. Having shown that the MOPEVAC vaccine, based on a hyperattenuated arenavirus, induces neutralizing Abs against Lassa fever, we hypothesized that expression of NWA glycoproteins in this platform might protect against NWAs. Cynomolgus monkeys immunized with MOPEVACMAC, targeting Machupo virus, prevented the lethality of this virus and induced partially NWA cross-reactive neutralizing Abs. We then developed the pentavalent MOPEVACNEW vaccine, expressing glycoproteins from all pathogenic South American NWAs. Immunization of cynomolgus monkeys with MOPEVACNEW induced neutralizing Abs against five NWAs, strong innate followed by adaptive immune responses as detected by transcriptomics and provided sterile protection against Machupo virus and the genetically distant Guanarito virus. MOPEVACNEW may thus be efficient to protect against existing and potentially emerging NWAs.
Fichier principal
Vignette du fichier
Reynard_S_Nat_Microbiol_2023.pdf (11.92 Mo) Télécharger le fichier

Dates et versions

hal-03931828 , version 1 (09-01-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Stéphanie Reynard, Xavier Carnec, Caroline Picard, Virginie Borges-Cardoso, Alexandra Journeaux, et al.. A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates. Nature Microbiology, 2023, 8 (1), pp.64-76. ⟨10.1038/s41564-022-01281-y⟩. ⟨hal-03931828⟩
74 Consultations
12 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More